Jean-Philippe Combal, Vivet CEO, will be attending a panel
Paris, France, April 24, 2019 – Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments
Vivet Therapeutics will be making a presentation on its lead product
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).
Vivet Therapeutics' CEO, Jean-Philippe Combal
Anne Douar, Chief Development Officer of Vivet Therapeutics
Jean-Philippe Combal, Vivet Therapeutics' CEO
Vivet Therapeutics CEO, Jean-Philippe Combal
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2018 London Healthcare Conference on…